International Stem Cell CORP Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
International Stem Cell CORP quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • International Stem Cell CORP Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $460K, a 28.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $460K -$186K -28.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $510K -$177K -25.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $557K -$170K -23.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $603K -$161K -21.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $646K -$154K -19.3% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $687K -$148K -17.7% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $727K -$141K -16.2% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $764K +$105K +15.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $800K +$67K +9.14% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $835K +$30K +3.73% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $868K -$6K -0.69% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $659K -$280K -29.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $733K -$273K -27.1% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $805K -$262K -24.6% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $874K +$157K +21.9% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $939K +$155K +19.8% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.01M +$157K +18.5% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $1.07M +$134K +14.4% Mar 31, 2020 10-Q 2020-06-19
Q4 2019 $717K Dec 31, 2019 10-K 2021-03-30
Q3 2019 $784K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $849K Jun 30, 2019 10-Q 2019-08-27
Q1 2019 $933K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.